Cytovation

Cytovation AS is a clinical-stage immuno-oncology company focused on developing its first-in-class targeted tumor membrane immunotherapy. The company’s product, CyPep-1, is a first-in-class tumor lysing agent that targets the cell membrane of tumor cells. Cytovation AS is a spin-off from the University of Bergen (Norway), where its headquarters is located.